Dr. Arthi Venkat, MD

Dr. Venkat practices at University of Virginia Physicians Group in Charlottesville, Virginia.

Dr. Venkat's NPI, 1013274919, was assigned on April 16, 2012. Dr. Venkat graduated from Georgetown University School of Medicine in 2012. Dr. Venkat holds Virginia license 0101270281.

Dr. Venkat's primary practice is University of Virginia Physicians Group, at 1300 Jefferson Park Ave, Charlottesville, VA 22903 in Charlottesville City. The practice phone is (434) 295-1000.

Dr. Venkat's primary practice is University of Virginia Physicians Group in Charlottesville, Virginia. Dr. Venkat is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Venkat to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Venkat practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Venkat's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Venkat's licenses on file in 2 states: Virginia and Maryland.

CMS data shows 2,112 Medicare services from Dr. Venkat across 8 procedure codes in 2024, for 500 Medicare patients. Medicare paid $88,097 for them.

CMS counts 500 Medicare patients who saw Dr. Venkat in 2024. The largest group is 65 to 74, with 202 patients. 73% of them have high cholesterol, and 71% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Venkat's median patient age at 64, with 60% women.

In 2024, Dr. Venkat wrote 402 Medicare Part D claims for 101 patients. 62% of them were for generic drugs. CMS names the drug for 376 of them, across 11 drugs with 11 or more claims each, at $93,425 in total drug cost. In 2023, CMS named 274 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Venkat for performance year 2024, reported as part of a group. Dr. Venkat accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Venkat, published from 2018 to 2025. 2020 was the busiest year, with 5. The most frequent topics are Tomography, Optical Coherence, Endophthalmitis and Uveitis. Dr. Venkat has published most often in Ophthalmic Surg Lasers Imaging Retina. Dr. Venkat's most frequent co-authors are Sunil K. Srivastava, MD, Careen Y. Lowder, MD and Sumit Sharma, MD.

CMS Open Payments shows 48 general payments to Dr. Venkat from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. Bausch & Lomb Americas Inc. paid the most, $3,533.

Dr. Venkat graduated from Georgetown University School of Medicine in 2012.